The Enteral Feeding Devices Market Share is expected to reach US$ XX Million at a CAGR of 4.9% between 2028. With the WHO at the helm of universal health coverage, all the communities across the globe are eligible to use curative, preventive, promotive, palliative, and rehabilitative health services of proper quality. In other words, qualitative healthcare would soon be the norm throughout.
The growth of the enteral feeding devices market is expected to be largely driven by the expansion of home enteral nutrition, the advantages of enteral nutrition over parenteral nutrition, and the growing global aging population, which is more susceptible to chronic diseases.
The development and adoption of innovative and patient-friendly enteral feeding devices is also expected to improve the market penetration and consumer preference for enteral feeding devices across all regions.
Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/12772
- Abbott Nutrition
- ALCOR Scientific
- Applied Medical Technology
- B. Braun Melsungen AG
- Boston Scientific
- CONMED Corporation.
- Cook Medical
- Cardinal Health, Inc.
- Becton, Dickinson and Company
- Fresenius Kabi
- Owens & Minor, Inc. (Halyard Health)
- Nestlé Health Science
- Danone SA
- Vygon SA
- Amsino International, Inc.
- Fuji Systems Corp
- Smiths Medical (Smiths Group)
The US to Remain Prominent Market for Enteral Feeding Devices Manufacturers
High healthcare spending and a strong homecare support infrastructure are among the factors that are expected to continue to drive the market, specifically the enteral pump market, in the US. Increased emphasis on patient mobility and the rapid adoption of such means in the US is estimated to promote the growth of low-profile enteral feeding devices.
However, factors hampering the growth of the enteral feeding devices market include stringent government regulations and reduction in the sales prices of several enteral feeding devices, even though the US already has the lowest average selling price among the seven major markets of enteral feeding devices in the world.
The development and adoption of innovative and patient-friendly enteral feeding devices is also expected to improve the market penetration and consumer preference for enteral feeding devices across all the regions. The growing global aging population and the trend toward homecare feeding are expected to be among the main factors propelling the enteral feeding devices market during the forecast period.
Increase in the prevalence of chronic conditions, such as cancer and premature birth, are also expected to contribute to the increased usage of enteral feeding devices for nutrition.
However, lack of patient education and reimbursement limitations in certain countries are some of the factors that are likely to hamper the adoption of enteral feeding devices. Parenteral feeding devices, which administer nutrition to patients via IV, have been competitors of enteral feeding devices for a long period. Several studies and articles have been published, which compare these two forms of nutrition, however, most physicians prefer enteral nutrition over parenteral nutrition.
Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/12772
Reimbursement Scenario to Remain among Key Influencers
Another major barrier that is restraining the growth of the enteral feeding devices market is the need for companies in the market to invest high amounts for R&D. However, depending upon the segment, entry into the enteral feeding devices market generally requires less extensive technological capabilities as compared to what is being seen in other medical device areas.
This is especially true for enteral feeding devices, such as nasogastric and replacement G-tubes, which are less technologically complicated and have a low R&D cost, due to which they are less difficult to manufacture. On the other hand, enteral feeding devices such as pumps have high R&D costs, require more technical expertise, have stringent approval regulations, and require companies to provide servicing & maintenance.
Accordingly, reimbursement structures present in different regions vary due to socioeconomic influences. Insurance agencies pose a major challenge to enteral feeding devices manufacturers to cut down on their operating funds. To succeed, manufacturers need to recognize that markets are different, and adjust their strategies in different areas to be able to achieve regional expansion.
The manufacturers of enteral feeding devices need to balance their advertising and technical studies to create better prospects. Moreover, they must confirm and effectually place their central product in their offerings in relation of its price intention.
Access Full Report @ https://www.persistencemarketresearch.com/checkout/12772
Established Players Present Extensive Product Portfolios, Number of New Entrants on Rise
The largest and most dynamic firms in the enteral feeding devices market offer comprehensive portfolios of enteral feeding devices. At present, the global enteral feeding devices market is dominated by key players such as Abbott Nutrition, Cardinal Health, Inc., Fresenius Kabi, Halyard Health, Nestlé, and Nutricia.
The less-known players in the enteral feeding devices market include Moog, which has no significance at the global level, however, it is a market leader in Japan. This provides a clear idea of the potential of the penetration of the global enteral feeding devices market.
Although the enteral feeding devices market is mature and highly competitive, most segments are either saturated or nearing saturation. Some of the new players in the enteral feeding devices market stand the chance of obtaining a sizable market share from the major players that are already present in the market, presence of new emerging players nevertheless creates downward pressure on more established enteral feeding devices manufacturers.
Access Related Reports:
Gynaecological Cancer Drugs Market:
The new report by Persistence Market Research (PMR) expects the global gynaecological cancer drugs market to witness significant growth, registering 6.2% CAGR during the forecast period. The global gynaecological cancer drugs market is also expected to bring in US$ 41,855.8 million revenue by the end of 2026.
Medical Oxygen System Market:
An analytical study of global medical oxygen system market, published by Persistence Market Research, estimates that global revenues secured from sales of medical oxygen systems reached an estimated US$ 2 billion by the end of 2016.
Ventilator Test System Market:
As per the forecast of Persistence Market Research, the global ventilator test system market is estimated to reach a valuation of US$ 199.2 Mn in 2026 and is poised to reflect a sluggish CAGR in the period of forecast.
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.
Persistence Market Research Address – 305 Broadway, 7th FloorNew York City, NY 10007 United States U.S. Ph. – +1-646-568-7751 USA-Canada Toll-free – +1 800-961-0353